Abstract
There has been a renewed interest in surface replacement arthroplasty over the last decade, with the hope and expectation that this procedure would provide an advantage over conventional total hip arthroplasty, especially in the young, active patient. More specifically, the promises of surface replacement arthroplasty have been: 1) preservation of bone stock so that future revisions would be easier, 2) potential to be minimally invasive in their approach, 3) better functional outcomes because of the stability associated with a larger femoral head with potential associated proprioceptive advantages, and 4) improved survivorship. Unfortunately, these promises have not been realised.
Surface replacement arthroplasty does maintain more initial bone stock on the femur, but also tends to remove more bone initially on the acetabular side. Long term, it is the loss of acetabular bone stock that is more problematic from a reconstructive perspective. Further, the “simple” revision afforded in surface replacement arthroplasty has led to reports of inferior clinical outcomes, especially with respect to subjective complaints of pain.
Surface replacement arthroplasty is more invasive than conventional total hip arthroplasty as the femoral head is maintained and the window to the acetabulum is subsequently partially blocked. This is exacerbated by the fact that many of these patients are young active males.
There is no compelling evidence that surface replacement arthroplasty offers improved functional outcomes over conventional total hip arthroplasty, particularly when considering gait and proprioception. Some studies have in fact shown inferior outcomes. The concept of the larger femoral head in surface replacement arthroplasty providing increased range of motion and subsequent better function is flawed as it is the head-to-neck ratio that appears to be a more important determinant of outcome in this sense. Total hip arthroplasty generally has a more favorable ratio.
Surface replacement arthroplasty has inferior survivorship to conventional total hip arthroplasty, even when accounting for the younger age of this patient cohort. This finding is consistent across multiple national joint replacement registries. The outcomes and survivorship are particularly poor in females, with many authors now advocating that the procedure be reserved for males.
Surface replacement arthroplasty has introduced several new problems and mechanisms of failures, most concerning of which is the formation of pseudotumors in some patients. It is unclear as to who is at risk for this significant complication, and the ability to diagnose and treat this disorder is difficult and still in evolution. Likely associated is the significant elevation of metal ions in the serum and urine of some surface replacement arthroplasty patients. Neck fractures and loss of bone stock around the femoral implant have also been noted as problematic for these devices. Some of these problems have led to specific surface replacement arthroplasty systems being recalled.
Finally, surface replacement arthroplasties are premium products with associated increased costs, which, frankly, are not justified.
